Life Insurance Corporation of India Stocks

803.65Last Updated 13.04.2026

Issuer Rating

6/7
Performance

Strong

Risk

Limited

Recommendation

Buy

Market Cap

₹ 54.44B

Buy
Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
803.65
Key Takeaways

Risk factor

Low price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly undervalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Life Insurance Corporation of India provides life insurance products in India, Fiji, Mauritius, and the United Kingdom. It provides individual products, including participating insurance products; and non-participating products comprising savings insurance, term insurance, health insurance, annuity and pension, and unit-linked insurance products; special products for women and children, micro insurance products; and riders, an add-on covers to the base policy to facilitate additional benefits linked to the accident, critical illness, and death and premium waiver benefit. The company also offers group products, such as group term insurance, group savings insurance, group savings pension, and group annuity products. Life Insurance Corporation of India was incorporated in 1956 and is based in Mumbai, India.

Company Valuation

Greatly undervalued
7/7

From both historical and forecast perspectives, the stock is considerably underpriced compared to similar stocks. In particular, the stock is underpriced on P/E, 'cheap'

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Somewhat favourable
5/7

The average target price of LICI.NS is 1144 and suggests 42% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to inc

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks